BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9455497)

  • 1. HLA-B alleles associated with the B15 serologically defined antigens.
    Steiner N; Ng J; Bush J; Hartzman RJ; Johnston-Dow L; Hurley CK
    Hum Immunol; 1997; 56(1-2):84-93. PubMed ID: 9455497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B15: a widespread and diverse family of HLA-B alleles.
    Hildebrand WH; Domena JD; Shen SY; Lau M; Terasaki PI; Bunce M; Marsh SG; Guttridge MG; Bias WB; Parham P
    Tissue Antigens; 1994 Apr; 43(4):209-18. PubMed ID: 7521976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B*15 diversity in the Korean population.
    Lee KW; Jeon H; Park JY
    Tissue Antigens; 2000 Nov; 56(5):428-35. PubMed ID: 11144290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific amino acid patterns define split specificities of HLA-B15 antigens enabling conversion from DNA-based typing to serological equivalents.
    Duygu B; Matern BM; Wieten L; Voorter CEM; Tilanus MGJ
    Immunogenetics; 2020 Sep; 72(6-7):339-346. PubMed ID: 32561995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism at codons 114, 116, 145, and 163 muddle the typing of HLA-B*1304.
    Ellexson M; Lai-Kwan P; Lau M; Muto K; Terasaki P; Cole J; Thompson C; Hildebrand W
    Hum Immunol; 1997 Jun; 55(1):66-73. PubMed ID: 9328792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA Class I typing of volunteers for a bone marrow registry: QC analysis by DNA-based methodology identifies serological typing discrepancies in the assignment of HLA-A and B antigens.
    Gourley IS; Kearns J; McKeen M; Birkos S; Brown M; Kamoun M
    Tissue Antigens; 2002 Mar; 59(3):211-5. PubMed ID: 12074711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of HLA-B35 alleles and their relationship to HLA-B15 alleles.
    Cereb N; Kim C; Hughes AL; Yang SY
    Tissue Antigens; 1997 Apr; 49(4):389-96. PubMed ID: 9151391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of HLA-A and -B serologic typing of bone marrow registry donors using polymerase chain reaction with sequence-specific oligonucleotide probes and DNA sequencing.
    Sintasath DM; Bei M; Steiner N; Ng J; Alosco S; Hegland JD; Hurley CK
    Tissue Antigens; 1997 Oct; 50(4):366-71. PubMed ID: 9349621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I variation in Australian aborigines: characterization of allele B*1521.
    Lienert K; McCluskey J; Bennett G; Fowler C; Russ G
    Tissue Antigens; 1995 Jan; 45(1):12-7. PubMed ID: 7725306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typing of HLA-B*15 alleles using sequence-specific primers.
    Yu N; Ohashi M; Alosco S; Salazar M; Cao K; Fernandez Vina M; Yunis EJ
    Tissue Antigens; 1998 Sep; 52(3):260-9. PubMed ID: 9802606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small test of a sequence-based typing method: definition of the B*1520 allele.
    Domena JD; Little AM; Arnett KL; Adams EJ; Marsh SG; Parham P
    Tissue Antigens; 1994 Oct; 44(4):217-24. PubMed ID: 7871522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarification of HLA-B serologically ambiguous types by automated DNA sequencing.
    Lee KW; Steiner N; Hurley CK
    Tissue Antigens; 1998 May; 51(5):536-40. PubMed ID: 9672152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further molecular diversity in the HLA-B15 group.
    Lin L; Tokunaga K; Tanaka H; Nakajima F; Imanishi T; Kashiwase K; Bannai M; Mizuno S; Akaza T; Tadokoro K; Shibata Y; Juji T
    Tissue Antigens; 1996 Apr; 47(4):265-74. PubMed ID: 8773315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B*1303: a new example of poor correlation between serology and structure.
    Balas A; García-Sánchez F; Vicario JL
    Hum Immunol; 1996 Jan; 45(1):32-6. PubMed ID: 8655357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the novel allele HLA-B*1545: assessment of alloreactivity in case of mismatch with other B*15 alleles.
    Elsner HA; Blasczyk R
    Tissue Antigens; 2000 Jan; 55(1):80-2. PubMed ID: 10703617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an HLA-B62 variant (B*1538) exhibiting an additional B52 serologic reactivity.
    Lee KW; Steiner N; Hurley CK
    Tissue Antigens; 1997 Dec; 50(6):662-4. PubMed ID: 9458123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel HLA-B alleles, B*8201, B*3515 and B*5106, add to the complexity of serologic identification of HLA types.
    Hurley CK; Steiner N; Hoyer RJ; Menchaca E; Mitton W; Simonis T; Hartzman RJ; Johnson AH; Ng J
    Tissue Antigens; 1996 Mar; 47(3):179-87. PubMed ID: 8740766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of HLA-B71 from an African American individual.
    Rodriguez SG; Johnson AH; Hurley CK
    Hum Immunol; 1993 Jul; 37(3):192-4. PubMed ID: 8244782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B*4021: hybrid linking the B15 and B40 families.
    Lee KW
    Tissue Antigens; 1999 Dec; 54(6):625-7. PubMed ID: 10674978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The search for HLA-matched donors: a summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens.
    Hurley CK; Schreuder GM; Marsh SG; Lau M; Middleton D; Noreen H
    Tissue Antigens; 1997 Oct; 50(4):401-18. PubMed ID: 9349626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.